Skip to content

Palvella Therapeutics PVLA Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$206.39M+173%$57.98M-30.6%$63.57M+228%$70.43M+257%$75.63M+296%
$1.38M-24.9%$1.01M-56.2%$1.15M+312%$1.34M+106%$1.84M-38.3%
$263.23M+231%$58.99M-33.1%$66.94M$73.75M$79.44M
$528K$572K
$55.46M$0
$263.76M+232%$59.56M-32.5%$66.94M+226%$73.75M+194%$79.44M+169%
$5.44M+22.6%$4.6M+0.2%$3.48M+335%$4.56M+370%$4.44M+193%
$209K$202K
$9.12M+1.5%$11.34M-5.8%$10.31M+142%$9.62M+51.5%$8.98M+19.2%
$375K$431K
$31.45M+31.8%$31.58M+23.2%$28.26M$25.97M$23.86M
$0$0$0$0
$14K+27.3%$12K+9.1%$11K+1,000%$11K+1,000%$11K+1,000%
$383.42M+143%$163.34M+4.5%$161.3M-53.0%$159.27M-53.5%$157.49M-54.0%
-$151.22M-48.4%-$135.45M-44.5%-$122.74M+62.4%-$111.39M+65.6%-$101.92M+68.1%
$95K+3,267%$83K+2,667%$104K+133%-$111K+74.5%-$3K+99.1%
$232.31M+318%$27.98M-55.3%$38.68M+144%$47.78M+159%$55.58M+172%
$263.76M+232%$59.56M-32.5%$66.94M+226%$73.75M+194%$79.44M+169%
$528K$572K
$528K$572K
$55.46M$0
$528K$572K
$0-100%$2.2M+11.0%$2.22M$1.98M$1.98M
$0-100%$2.2M+11.0%$2.22M$1.98M$1.98M
$2.16M+25.3%$2.04M+23.9%$1.92M$1.84M$1.72M
$584K$633K
$14K+27.3%$12K+9.1%$11K+1,000%$11K+1,000%$11K+1,000%
$3.46M+35.1%$4.35M-20.5%$4.62M$3.08M$2.56M
$2.16M+25.3%$2.04M+23.9%$1.92M$1.84M$1.72M
$19.8M+50.5%$17.76M+48.7%$16.02M$14.51M$13.16M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Palvella Therapeutics's total assets?
Palvella Therapeutics (PVLA) holds $263.8M in total assets, up 232.0% year over year.
How much debt does Palvella Therapeutics have?
Palvella Therapeutics carries $584.0K in total debt against $232.3M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Palvella Therapeutics have?
Palvella Therapeutics holds $206.4M in cash and equivalents.
Can Palvella Therapeutics cover its short-term obligations?
Its current ratio is 28.88 — current assets exceed current liabilities.
Where does Palvella Therapeutics's balance sheet data come from?
Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.